Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Germinator Mobile Sanitizing and Disinfecting Launches in Greensboro, North Carolina


A Germinator field specialist performing sanitizing and disinfecting services.

We are excited for the continued expansion of our services throughout North Carolina,” said Jeff Gill, CEO of Germinator. “The pandemic has presented the world with unprecedented circumstances, and we aim to do our part in helping to reduce the spread of harmful bacteria, germs and viruses.

Germinator Mobile Sanitizing and Disinfecting https://www.thegerminator.com/, a broad-spectrum sanitization, disinfection and deodorization provider, is proud to announce it has opened a location in Greensboro, North Carolina. Clemente McWilliams will own and operate the franchise, which will provide door-to-door sanitizing and disinfecting services to commercial and residential properties.

McWilliams brings nearly 30 years of corporate management experience, entrepreneurship, and community engagement to Germinator. In addition to the Greensboro location, he plans to open a Germinator franchise in Raleigh, North Carolina in the coming months.

“I’ve always been an advocate for change and for transformational efforts that lead to more effective outcomes,” said McWilliams. “The current pandemic has been eye opening for me, my family and friends. During these difficult times, we want to focus our efforts on helping our community. I truly believe Germinator is a game-changer in the sanitizing and disinfecting business, enabling all of us to feel safe and confident that we can thrive in our environments.”

The Greensboro franchise is the third Germinator location to launch in North Carolina. The company also recently announced the opening of franchises in Charlotte and Durham.

“We are excited for the continued expansion of our services throughout North Carolina,” said Jeff Gill, CEO of Germinator. “The pandemic has presented the world with unprecedented circumstances, and we aim to do our part in helping to reduce the spread of harmful bacteria, germs and viruses.”

Germinator provides a 100% safe and non-toxic sanitizing and disinfecting process, utilizing breakthrough technology scientifically proven to help reduce the spread of harmful bacteria and viruses similar to the novel coronavirus.

The company utilizes a two-step process to sanitize and disinfect surfaces as well as provide long-lasting protection against odor-causing bacteria, bacteria which cause stains and discoloration and fungi such as mold and mildew, and algae. The first step – Genesis – harnesses the power of hypochlorous acid (HOCl) to destroy bacteria, mold, mildew, viruses and odors caused by bacteria. HOCI is a non-toxic, near-neutral pH, hospital-grade sanitizer and disinfectant. The second step applies the Germinator’s Shield – an invisible microbial coating that protects surfaces for an extended period of time against the growth of mold, mildew and odor-causing bacteria. Both products are EPA registered and safe for humans, pets and the environment. The company’s highly trained field specialists employ best practices using electrostatic sprayers and wear Personal Protective Equipment (PPE) as appropriate.

Upholding the highest standards of sanitization and disinfecting, Germinator makes claims that are scientifically supported and within EPA regulations. In an effort to research and further validate its practice of sanitizing and disinfecting surfaces, the company recently created the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr – who was an Assistant to the United States Surgeon General for five administrations.

“During these unprecedented times, the need to focus on sterilizing agents within our country’s airports, public spaces, and offices in order to decrease the spread of viral pathogens such as Coronavirus is essential,” states Dr. Moore. “I am extremely happy to be a part of the Germinator team and lend my expertise in public health and regulatory affairs to what I feel is an immense asset to the containment effort.”

Germinator was founded by Jeff Gill in 2015, with the vision of providing a safe, effective and non-toxic method of proper sanitizing and disinfecting for businesses and households. Since February, the company has launched Germinator locations in major cities across the U.S.

The company continues to expand across the country, providing communities with a proactive solution to help free environments from harmful germs, bacteria, and viruses. With Germinator, society can now have peace of mind and the freedom to live or work in a sanitized and disinfected environment. Businesses and residents in the Greensboro area can learn more by visiting http://www.germinatorgreensboro.com or calling (336) 530-2900.

Share article on social media or email:

EMMA International Consulting Group, Inc. Named to the 2020 Inc. 5000 List


News Image

“We are so pleased to be named to this year’s Inc. 5000 list. This is a direct reflection of the hard work and dedication of the EMMA International team for being on the forefront of FDA compliance and the advancement of innovation in life sciences,” said Kira Jabri, EMMA International’s CEO.

Inc. magazine today revealed that E.M.M.A. International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting has been named on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“We are so pleased to be named to this year’s Inc. 5000 list. This is a direct reflection of the hard work and dedication of the EMMA International team for being on the forefront of FDA compliance and the advancement of innovation in life sciences,” said Kira Jabri, EMMA International’s CEO.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

About EMMA International

EMMA International Consulting Group, Inc. is a global leader in FDA compliance consulting, with headquarters in Bingham Farms, MI. We focus on quality, regulatory, and compliance services for the biotechnology, pharmaceuticals, and medical device industries.

EMMA International is certified to ISO 9001:2015, a globally recognized quality management standard developed by the International Organization for Standardization (ISO).

EMMA International is certified as a Women’s Business Enterprise (WBE) through the Women’s Business Enterprise National Council (WBENC), the nation’s largest third-party certifier of businesses owned and operated by women in the US.

For more information, visit http://www.emmainternational.com/.

If you would like additional information, please contact Katie McCallum, Marketing and Operations Specialist at 248-987-4497 or email at katie.mccallum@emmainternational.com.

Share article on social media or email:

Inc. Magazine Unveils Its Annual List of America’s Fastest-Growing Private Companies—the Inc. 5000


News Image

We are so thrilled that RxAdvance has established itself as a transformative partner with whom entities across the healthcare industry can reduce healthcare costs and improve patient outcomes.

Inc. magazine today revealed that RxAdvance Corporation is No. 426 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“RxAdvance is honored to be recognized by Inc. 5000 for our growth trajectory. In recent years, our industry has seen immense pressure to transform in a manner that leverages innovative technology and business & risk models to improve healthcare,” said Ravi Ika, RxAdvance President & CEO. “We are so thrilled that RxAdvance has established itself as a transformative partner with whom entities across the healthcare industry can reduce healthcare costs and improve patient outcomes.”

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000. The top 500 companies are also being featured in the September issue of Inc., available on newsstands August 12.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

The annual Inc. 5000 event honoring the companies on the list will be held virtually from October 23 to 27, 2020. As always, speakers will include some of the greatest innovators and business leaders of our generation.

RxAdvance, based in Southborough, MA, is a healthcare Platform, SaaS, and Cloud services company that reduces overall administrative, medical, and pharmacy costs. The company provides transformative solutions across both the payer and pharmacy benefit management (PBM) industries, which together are responsible for managing a majority of the $3.5 trillion annual U.S. healthcare spend. RxAdvance currently has 200+ employees, over 75% of whom are Generation Z and Millennials, and prides itself on its bustling culture and diverse workforce. RxAdvance has grown rapidly since the company’s inception in 2013, with a current annual revenue of approximately $2 billion. The company expects to double its workforce by the middle of next year and is moving into a new 80,000 square foot campus in the Boston suburbs this fall to support such growth.

CONTACT: For additional information, contact Elizabeth Thomas, Director of Strategy, at elizabeth.thomas@rxadvance.com.

More about Inc. and the Inc. 5000

Methodology

The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at http://www.inc.com/inc5000.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

For more information on the Inc. 5000 Conference, visit http://conference.inc.com/.

Share article on social media or email:

Creekwood Dental Arts Voted #1 Best Dentist in Waco by Locals Love Us Two Years in a Row


Creekwood Dental Arts, Award-Winning Dental Team in Waco, TX.

Creekwood Dental Arts Voted #1 Best Dentist in Waco Two Years Running

There’s a real camaraderie in the office. Our team enjoys spending time together and interacting with patients. It creates a more relaxed setting for patients

General and cosmetic dentistry practice, Creekwood Dental Arts recently ranked #1 on the Locals Love Us list for the second year in a row and was voted The Best Dentist in Waco by their patients. The practice offers the expertise of award-winning dentist in Waco, TX, Dr. Donna Miller and two additional associates, Drs. Michelle Hinds and Austin Green, as well as an experienced and friendly staff.

The “Best Dentist in Waco” title is awarded through Locals Love Us Waco, a website that allows members of the community to vote in over 200 different categories for their favorite local businesses. With only a maximum of five winners per category, dentistry is one of the most sought-after and competitive categories on the list. Votes are cast by patients of each participating dental practice, and those with the most votes win the title of Best Dentist in Waco. The team at Creekwood Dental Arts is pleased their practice received this esteemed title and are delighted that their patients’ votes have again earned them top ranking in the Locals Love Us dentist directory on the website.

The dentists at Creekwood Dental Arts, led by Dr. Miller, who was also voted 2016 Texas Dentist of the Year™ from the Texas Academy of General Dentistry, are pleased to continue providing the dedicated and compassionate dental care that helped them win the Best Dentist award. The team surpasses standards in their high-quality treatments, using sophisticated technologies and techniques to provide personalized and efficient general and cosmetic dentistry services, including crowns and bridges, orthodontics, porcelain veneers and professional teeth whitening. This team of dentists also has extensive experience in family dentistry as well as laser dentistry, teeth-in-a-day dental implants and sedation dentistry.

“There’s a real camaraderie in the office,” said Dr. Hinds. “Our team enjoys spending time together and interacting with patients. It creates a more relaxed setting for patients.” The rest of the dental team and patients alike agree that Creekwood Dental Arts is one of the best practices to go to for friendly, caring and personalized dental care. With the Best Dentist in Waco title, the dentists are excited to help even more patients restore their smiles in a comfortable and safe atmosphere.

Patients interested in general or cosmetic dentistry services can contact the dentists in Waco, TX. Creekwood Dental Arts can be reached by calling 254-870-9026 or visiting CreekwoodDentalArts.com.

About the Practice

Creekwood Dental Arts is a general dental practice offering personalized dental care to patients in Waco, TX. Drs. Donna G. Miller, Michelle Hinds and Austin Green provide an array of services with state-of-the-art technology. Dr. Miller was voted the Texas Dentist of the Year™ from the Texas Academy of General Dentistry as well as accomplished The Mastership Award from the Academy of General Dentistry, the highest and most respected award in general dentistry. Creekwood Dental Arts is also an award-winning team, over the last two years they have received The Best Dentist Award by Locals Love Us Waco. To learn more about Drs. Miller, Hinds and Green or the services they offer, please visit their website at CreekwoodDentalArts.com or call 254-870-9026 to schedule an appointment.

Share article on social media or email:

EyeControl Secures $10 Million from COVID-19 Pilot Program & Series A Round Investments to Commercialize AI-Powered Communication Solution for Ventilated ICU Patients


News Image

EyeControl, a leading supplier of assistive communication devices for ventilated and “locked-in” patients, today announced it has closed a Series A round of funding and has won the Enhanced European Innovation Council’s (EIC) COVID-19 Pilot Program, securing over $10M in combined funding.

EyeControl becomes the first Israeli company to be awarded both the European Commission’s (EC) Horizon 2020 SME instrument phase 2 program and the EIC Accelerator. The new funding will allow the company to grow by expanding its hospital activity and enhancing strategic partnerships. EyeControl also announced that digital health entrepreneur Avner Halperin has been appointed as chairman of its newly expanded board of directors.

“I am very excited and proud to take part in EyeControl’s mission to improve communication for ventilated patients,” said Halperin. “Management has led the company to great achievements, including the recent EIC win. The EC recognizes that EyeControl is solving a critical issue with tremendous global impact. This funding will assist the company in accelerating growth and strategic partnerships worldwide.”

The company’s latest investment round, led by Connecticut Innovations, includes Benslie International Ltd, Clive Barret and Menomadin Foundation with participation from existing investors, including Benny Levin (founder and former CEO of NICE), Itsik Danziger (former president of Comverse), Jim Elkind (private healthcare investor), Avi Kornreich (former CEO of Agentek), Zora Ventures, Impact First and Rimonci Capital.

“The combined support of the new board members joining as part of this funding round, as well as the continued support of the EC, paves the way for EyeControl’s future success,” said Matt Bloom, investments director at Connecticut Innovations and EyeControl board member. “With its innovative technology and bright team, we strongly believe this company will stand out and is well positioned for success.”

EyeControl’s funding milestones have been achieved against the backdrop of the COVID-19 pandemic, which fueled the preexisting need for an innovative communication solution for ventilated patients in a medical facility environment. The company is piloting its medical device at hospitals treating patients with COVID-19, helping preserve lines of communication between ventilated patients and nurse stations outside quarantine.

“We are very thankful to our new and existing investors for their trust and financial support as well as the access we have to their expertise and professional networks,” says Or Retzkin, EyeControl’s CEO and co-founder. “The appointment of Avner Halperin as chairman of the board will accelerate the company’s growth potential. His extensive experience will play a crucial role in bringing our disruptive technology to the forefront of global healthcare.”

About EyeControl:

EyeControl is an Israeli startup established in 2016 by three entrepreneurs who share unique personal connections to locked-in individuals; they joined forces to create innovative solutions for the communication needs of these patients.

The EyeControl is the first wearable, screenless assistive communication device. AI-powered eye-tracking technology enables remote communication between ventilated ICU patients, their families and medical care teams. The EyeControl also improves quality of life for ventilated and locked-in home care patients, by providing round-the-clock communication with family members and caregivers. The EyeControl is CE marked, FDA listed and ISO certified. It is reimbursed by the U.S. Centers for Medicare and Medicaid Services, UK National Health Service and the Israeli Ministry of Health.

Share article on social media or email:

Resoundant Expands Its Research Services Footprint


MRE and PDFF biomarker analysis from Resoundant

Advanced biomarker analysis from Resoundant

Our continuing goals are to help move [NAFLD and NASH] projects forward at a lower cost and with greater technical capacity than ever before.

Resoundant, Inc. announced today that the company is expanding its clinical research services in collaboration with the scientists and medical professionals at Mayo Clinic.

In recent years, clinical research to address chronic liver diseases, such as non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD), has accelerated tremendously. Resoundant has been increasingly involved in advising and providing core lab services for numerous high-profile Phase IIa and Phase IIb trials in these areas.

In response to this growing global demand, Resoundant has made significant investments to expand its suite of clinical research services. These new services include access to Resoundant/Mayo Clinic analysts for central image reads, secure data management, quantitative reporting, site training and identification, regulatory support, study start-up/close-out support, quality control, and proprietary in-house analytics.

Resoundant has focused primarily on two technologies that have become widely applied in clinical trials focused on liver disease: Magnetic Resonance Elastography (MRE) and imaging of proton density fat fraction (PDFF). Both MRE and PDFF are recognized as well-validated, best-in-class MRI technologies for assessing liver fibrosis and steatosis respectively. These non-invasive technologies are routinely deployed in trials as key biomarkers due to their rapid acquisition protocols, superior accuracy, repeatability, and wide availability.

“These imaging-based biomarkers are powerful tools in clinical trials and in clinical management of liver disease,” said Richard Ehman, MD, professor of radiology and the Blanche R. & Richard J. Erlanger Professor of Medical Research at Mayo Clinic, and Chief Executive Officer of Resoundant.

“We’re extremely fortunate to be able to tap the expertise and technical know-how of the team that pioneered the development and translation of MRE at Mayo Clinic. Our continuing goals are to help move these projects forward at a lower cost and with greater technical capacity than ever before.”

Since 2017, Resoundant and Mayo Clinic staff have consulted or served as a core laboratory on nearly a dozen trials in the liver disease arena, providing analysis services for thousands of MRE and PDFF exams for indications such as NAFLD, NASH, hepatitis C, hepatitis B, and primary biliary cholangitis.

“This is a very natural expansion for our company,” said Kathy Anderson, JD, Chief Operating Officer of Resoundant. “Our close connections with Mayo Clinic, as well as with talented contract research organizations across the globe, has resulted in sustained organic growth for our clinical trial services.”

To learn more about Resoundant’s Clinical Trial Services, visit: http://www.resoundant.com/clinical-trials or email clinicaltrials@resoundant.com

About MR Imaging for Chronic Liver Disease

Quantitative imaging technologies offer powerful capabilities to address the global problem of chronic liver disease. For many patients, MRE can serve as a reliable, less expensive, and safer alternative to biopsy to diagnose and stage liver fibrosis.

The technical advantages of MRE for assessing fibrosis and PDFF for assessing liver fat have been well-validated in dozens of studies against paired biopsies, with high degrees of inter-reader agreement and repeatability. Both biomarkers have also been standardized across various vendor platforms and field strengths and utilize the same quantitative cutoffs regardless of the underlying etiology (viral hepatitis, fatty liver disease, etc.) – making them ideal for clinical research. Neither is significantly affected by common co-morbidities that can cause failure in complementary ultrasound-based techniques, such as obesity.

About MRE

MR Elastography was invented at Mayo Clinic. It is widely available to clinicians at over 1,500 locations across the globe and is the only MRI technology that has been validated for staging liver fibrosis. Clinicians and patients can find U.S. locations at MRE:connect (http://www.resoundant.com/mre-connect). The role of MRE has been increasingly recognized in multidisciplinary clinical guidelines for routine liver fibrosis assessment, particularly in suspected cases of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The American College of Radiology issued Appropriateness Criteria® that identify MRE as the most accurate and applicable noninvasive liver fibrosis exam. MRE is reimbursed via a Category I CPT® code (76391) and is covered by numerous public and private insurance plans.

About Resoundant, Inc.

Resoundant, Inc. is a medical technology company dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance Elastography (MRE) available around the world. Resoundant is based in Rochester, MN and was founded by Mayo Foundation for Medical Education & Research, Mayo Clinic physicians and researchers.

For more information, go to http://www.resoundant.com

Mayo Clinic and Dr. Ehman have a financial interest in the technology referenced in this news release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.

Share article on social media or email:

Allergy Amulet Secures $3.3 Million To Launch World’s Smallest and Fastest Consumer Food Allergen Sensor


News Image

Allergy Amulet is slated to be the most affordable, fastest, and sleekest food sensor on the market. We want to build a better future for the food allergy community, because the more tools we have in our toolboxes, the better that future will be.

Allergy Amulet, the company empowering the food allergy community by alleviating fears about what’s in their food, today announces $3.3 million in seed funding led by TitletownTech, a joint venture between Microsoft and the Green Bay Packers. The company has developed the world’s smallest and fastest consumer food allergen sensor, which is capable of testing foods for common allergenic ingredients in seconds. The patented technology fits on a keychain, a necklace, a wristband, or in a pocket, and doubles as a medical alert system, making it easier and safer to manage food allergies and intolerances.

Food allergies affect 32 million Americans and between 220 to 520 million people globally—that’s one in 13 children and one in 10 adults. They can be fatal, even after ingesting only trace amounts of a known allergen.

Allergy Amulet helps:

  • Individuals with food allergies: It makes testing for food allergens easy, giving people additional assurances that their food is safe.
  • Parents with children who have food allergies: It gives parents another tool to manage their children’s allergies, and helps children live a normal childhood, maintain independence, and safely attend sleepovers and birthday parties (or just school) with friends.
  • Businesses: It gives restaurant owners, schools, childcare providers, summer camps, and hotels the power of extra precaution to save them time, money, and worry.

“The current standard of care — avoiding certain foods, injecting epinephrine to treat reactions, and visiting the emergency room — can take a serious emotional, financial, and physical toll on individuals, caregivers, and families,” said Abigail Barnes, Co-founder and CEO of Allergy Amulet. “Our hope is to help individuals more safely engage in the activities that bring them joy, whether that means going to a restaurant with friends and family or eating a cupcake at a party.”

How It Works

The Allergy Amulet is a fast and portable food allergen and ingredient sensor, designed to fit every lifestyle. Its first-of-its-kind detection platform pairs molecularly imprinted polymer (MIP) technology with a conductive electrochemical platform to detect target allergenic ingredients. The Amulet consists of two parts: a USB-sized reader (the “Amulet”) and a test strip that houses the proprietary sensor chips. The case also accommodates epinephrine and antihistamines, giving users a complete allergy care management platform.

For consumers, testing for food allergens is made possible in four simple steps:

  • Step 1: Users collect a sample of the food with the test strip, and turn the top of the tester to grind the sample.
  • Step 2: A chip slides out from the test strip and is inserted into the reader.
  • Step 3: Test results appear on the reader within seconds, indicating the presence or absence of the target allergen.
  • Step 4: Optional: store test results in the mobile app, connect and share results with the food allergy community, or hold down a button on the reader to alert your emergency contacts.

“Allergy Amulet is not only leading advancements in the field of imprinted sensor technology, they’re also spearheading a new product category that will vastly improve the quality of life for millions of individuals with food allergies and intolerances,” said Neil Mix, partner at TitletownTech. “Further, we saw the potential for broader food safety applications beyond allergens, including foodborne pathogens and contaminants. This is just the beginning, and we’re thrilled to help the team take this on.”

The Team

The Allergy Amulet team has deep connections to the communities they serve — Barnes has managed life-threatening food allergies since childhood, and experienced a near-fatal anaphylactic event as a teenager. After meeting her Co-founder and Scientific Advisor, Dr. Joseph BelBruno, a Dartmouth chemistry professor emeritus with life-threatening food allergies, the two worked to make Allergy Amulet a reality.

The company holds one issued U.S. patent with multiple applications, and its waitlist has thousands of individuals signed up to participate in an early beta release, scheduled to kickoff later this year.

This infusion of new capital will be used to manufacture beta units, help to launch pre-orders, expand product offerings to cover more allergens, grow the company’s world-class team, add additional restaurant and company partners to its roster, and educate consumers on the benefits of additional food allergen management tools. In addition to Titletown, its seed financing includes participation from Great North Labs, Colle Capital, Great Oaks VC, DeepWork Capital, Dipalo Ventures, and Bulldog Innovation Group.

“Allergy Amulet is slated to be the most affordable, fastest, and sleekest food sensor on the market,” said Barnes. “We want to build a better future for the food allergy community, because the more tools we have in our toolboxes, the better that future will be.”

Allergy Amulet is slated for pre-sales Fall of 2020 and launch Fall of 2021.

About Allergy Amulet

Allergy Amulet empowers the food allergy community to feel secure in their everyday lives by alleviating fears about what’s in their food. As the world’s smallest and fastest consumer food allergen sensor, Allergy Amulet is designed to fit into every lifestyle, whether on a keychain, a necklace, a wristband, or in a pocket. The company’s patented technology tests for common allergenic ingredients in seconds, allowing users to savor life’s important moments, safely and simply. Learn more at http://www.allergyamulet.com.

Share article on social media or email:

Planet DDS Announces the Acquisition of Apteryx Imaging Inc.


“Planet DDS and Apteryx offer substantial value propositions to the dental industry, which this acquisition will allow us to enhance moving forward,” stated Eric Giesecke, chief executive officer for Planet DDS.

Planet DDS is pleased to announce the closing of the previously announced acquisition of Apteryx Imaging Inc. Planet DDS has acquitted 100% of Apteryx Imaging In.’s outstanding common and preferred shares for CAD$0.65 per share in an all-cash transaction.

“Planet DDS and Apteryx offer substantial value propositions to the dental industry, which this acquisition will allow us to enhance moving forward,” stated Eric Giesecke, chief executive officer for Planet DDS. “Today is the beginning of a bright future for both Planet DDS and Apteryx. The entire Planet DDS family is excited to welcome Apteryx to our team.”

Founded in 2003, Planet DDS is the largest independent provider of cloud-native practice management systems to the dental industry with their Denticon software. Apteryx develops a line of award-winning imaging software technologies, including XrayVision and XVWeb, along with the VELscope oral screening device and TUXEDO intraoral sensors.

“The Planet DDS team has been instrumental in the growth of our company as a key partner for our XVWeb cloud imaging software,” stated Dr. David Gane, CEO of Apteryx Imaging. “We feel the synergies between the Planet DDS and Apteryx teams will have a very positive impact on the growth of both organizations moving forward.”

The Apteryx common shares are expected to be delisted from the TSX Venture Exchange at the close of business on or about August 13, 2020 and Apteryx will apply to cease to be a reporting issuer in British Columbia, Alberta and Ontario.

Full details of the Transaction are set out in the management information circular of the Company dated July 6, 2020 (the “Circular”). Registered Apteryx shareholders should send their completed and executed letters of transmittal and Apteryx share certificates to the depositary, Computershare Trust Company of Canada, as soon as possible in order to receive the consideration to which they are entitled to in connection with the Transaction. For those shareholders of Apteryx whose shares are registered in the name of a broker, investment dealer, bank, trust company, trust or other intermediary or nominee, they should contact such nominee for assistance in depositing their shares and should follow the instructions of such intermediary or nominee.

For more information on Planet DDS and Denticon, please visit http://www.planetdds.com. For details on Apteryx products and services, visit http://www.apteryx.com.

About Apteryx Imaging Inc.

Apteryx has provided dentists and oral health specialists with advanced diagnostic imaging software and device technologies for over 20 years. Apteryx’s proprietary technologies include XrayVision, XVWeb and XrayVision DCV imaging software solutions, the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors.

Backed by an experienced leadership team and dedicated to a higher level of service and support, Apteryx is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

For more information about Apteryx, its products and services, please visit http://www.apteryx.com or call 877-278-3799.

About Planet DDS and Level Equity

Planet DDS is the largest independent provider of cloud-native practice management software to the dental industry. The company’s flagship product, Denticon, is the only proven, time-tested software offering that was built from the ground up for multi-location groups in the cloud. Denticon has the largest footprint among emerging and established dental groups of any cloud software provider, allowing clients to break free from the constraints of desktop software with a comprehensive solution that includes the tools needed to standardize, centralize, and grow. All while reducing IT cost and enhancing security. Learn more about Denticon at http://www.planetdds.com. Planet DDS is a portfolio company of Level Equity Management, LLC (“Level Equity”).

Level Equity is a growth equity firm focused on providing capital to rapidly growing software and internet companies. The firm has raised over $1.7 billion across a series of long term committed investment partnerships with offices in New York, NY and San Francisco, CA. For more information about Level Equity, visit http://www.levelequity.com.

Share article on social media or email:

ESO Named to Inc. 5000 Fastest Growing US Companies List for Eighth Straight Year


News Image

We look forward to many years of growth as we help organizations improve the health and safety of their communities.

ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, and state EMS/Trauma offices, announced today it has been named to the 2020 Inc. 5000 list of fastest-growing companies in America for the eighth straight year at 1,765. The list honors and recognizes private companies that demonstrate the highest growth over a three-year period.

“We wouldn’t be in this position without a passionate and dedicated team driven to ensure our customers succeed,” said Chris Dillie, President and CEO of ESO. “We look forward to many years of growth as we help organizations improve the health and safety of their communities.”

ESO’s growth continues in 2020 with new customers, strong customer retention and an enhanced product ecosystem for healthcare and public safety providers and responders to track data and insights, from 911 call to leaving the hospital. These efforts are particularly necessary during the COVID-19 pandemic, leading to the creation of the ESO COVID-19 Resource Center.

Not only have the companies on the 2020 Inc. 5000 been very competitive within their markets, but the list as a whole shows staggering growth compared with prior lists as well. The 2020 Inc. 5000 achieved an incredible three-year average growth of over 500 percent, and a median rate of 165 percent. The Inc. 5000’s aggregate revenue was $209 billion in 2019, accounting for over 1 million jobs over the past three years.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at http://www.inc.com/inc5000.

About ESO

ESO (ESO Solutions, Inc.) is dedicated to improving community health and safety through the power of data. Since its founding in 2004, the company continues to pioneer innovative, user-friendly software to meet the changing needs of today’s EMS agencies, fire departments, hospitals and state EMS offices. ESO currently serves thousands of customers throughout North America with a broad software portfolio, including the industry-leading ESO Electronic Health Record (EHR), the next generation ePCR; ESO Health Data Exchange (HDE), the first-of-its-kind healthcare interoperability platform; ESO Fire RMS, the modern fire Record Management System software platform; trauma, burn and stroke registry software; and ESO State Repository. ESO is headquartered in Austin, Texas. For more information, visit http://www.eso.com.

Share article on social media or email:

Hand & Stone Massage and Facial Spa Appoints John Teza as President and Chief Development Officer and Announces Other Changes to the Executive Team


John Teza has been added to the team as President and Chief Development Officer starting August 10th. John has C-level experience in the restaurant and franchise space including his time as Chief Development Officer at Jersey Mike’s Subs where he directed all aspects of brand expansion for the NJ-based chain of 1,750+ units and $1.2 billion in system-wide sales. Most recently he was a Principal at NRD Capital Management leading operational and strategic functions for a number of restaurant and retail concepts.

John will immediately head all franchise, real estate and business development efforts for Hand & Stone. John will also supervise legal and compliance matters and have full responsibility for Company store operations. Based on his prior Canadian franchise experience, John will also oversee the 31-spa Canadian operation, working in conjunction with the brand’s current Canadian president.

“We are excited to have an executive of John’s caliber and experience join the Hand & Stone team. As we position the Company for continued accelerated growth and transition we need executives like John who bring high energy and tested leadership skills to the business,” noted Todd Leff, CEO of Hand & Stone.

“I am very excited about this opportunity and to join this team. The current group under the leadership of CEO, Todd Leff, has made Hand & Stone the fastest growing concept in a very dynamic industry and I am confident that my background and expertise can help extend this growth even further,” said Teza.

Current Vice President of Franchise Development, Bob McQuillan, has announced his retirement at the end of August. Bob has been at Hand & Stone for over 11 years and in that time has been instrumental in building the current franchise base to 475 spas. The entire executive team and Board acknowledge the efforts Bob has expended in those 11 years and how the brand would not be in the place it is today without his efforts. He will pursue more family and philanthropic endeavors in his retirement.

Separately, Cindy Meiskin has been elevated to Chief Experience Officer where she will continue to be responsible for the brand experience through franchisee training, consumer research and feeback platforms, brand compliance and other consumer experience functions. Cindy joined Hand & Stone in 2012 and was most recently the Vice President of Brand Experience.

“Especially during the recent COVID period, Cindy has demonstrated an amazing ability to synthesize various processes across the company into a one very clear direction for our consumer experience. She worked exhaustively in analyzing local, state and federal requirements and combining those with our own and outside industry expert analysis to help develop our reopening guidelines. She was the driving force behind our post-opening COVID strategy that is not only the envy of others in our space but the envy of the entire retail segment,” said Todd Leff, CEO of Hand & Stone.

About Hand & Stone Massage and Facial Spa

Hand & Stone is a 475-plus unit massage and facial spa franchise with a mission to bring massage and facial services to the masses. Launched in 2004, Hand & Stone now has locations in 33 states and Canada. The brand has been named number #1 in the spa category by Entrepreneur Magazine for 2020, ranked number #8 on Forbes’ Best Franchises to Buy list for 2019 in the high investment category and is the fastest growing spa concept in the country. For more information on Hand & Stone, visit handandstone.com

Share article on social media or email: